Category: us corporate news

us corporate news

Corcept Therapeutics Provides Update on Patent Dispute With Teva Pharmaceuticals Over Korlym Generic – Court Rules No Infringement

Minichart

February 20, 2026

Key Points from the Report Federal Court Ruling: The Un...

Continue Reading 0

us corporate news

Vicor Corporation Reports Record 2025 Financial Results with Strong Revenue Growth and Optimistic 2026 Outlook

Minichart

February 20, 2026

Vicor Corporation Q4 and Full Year 2025 Financial Results: D...

Continue Reading 0

us corporate news

Chemours Company Reports Q4 and Full Year 2025 Financial Results, Provides 2026 Outlook and Strategic Updates

Minichart

February 20, 2026

Chemours Reports Q4 and Full Year 2025 Results: Key Investor...

Continue Reading 0

us corporate news

Kentucky First Federal Bancorp Announces Termination of OCC Agreement and Improved Regulatory Status

Minichart

February 20, 2026

Kentucky First Federal Bancorp Announces Termination of OCC ...

Continue Reading 0

us corporate news

Consolidated Edison (Con Edison) 2025 Q4 Earnings Results: Clean Energy Businesses Sale, Financial Highlights & Attachments

Minichart

February 20, 2026

Consolidated Edison Reports 2025 Full Year and Q4 Results – ...

Continue Reading 0

us corporate news

Select Medical Holdings Reports Strong 2025 Financial Results, Announces 2026 Outlook, Dividend, and Stock Repurchase Program

Minichart

February 20, 2026

Overview and Key Financial Results Select Medical Holdi...

Continue Reading 0

us corporate news

Plexus Corp. Form 8-K Filing Details, Company Information, and XBRL Data (Feb. 18, 2026)

Minichart

February 20, 2026

Plexus Corp. 2026 Annual Meeting Results: Key Shareholder In...

Continue Reading 0

us corporate news

ManpowerGroup Inc. 8-K Filing February 2026: Change of Control, Executive Agreements, and Key Legal Disclosures

Minichart

February 20, 2026

ManpowerGroup Inc. 8-K Filing: Executive Agreements and Shar...

Continue Reading 0

us corporate news

Destra Multi-Alternative Fund Announces Board Member Resignation and Provides Fund Updates

Minichart

February 20, 2026

Destra Multi-Alternative Fund Announces Board Member Resigna...

Continue Reading 0

us corporate news

HCW Biologics Announces $1.5 Million At-The-Market Offering to Advance Immunotherapy Clinical Trials

Minichart

February 20, 2026

HCW Biologics Announces \$1.5 Million At-The-Market Follow-O...

Continue Reading 0